Name
4B: Combatting and exploiting dsRNA viruses
Date & Time
Thursday, October 13, 2022, 10:45 AM - 12:00 PM
Speakers
Session Chair: Viviana Parreño - National Institute of Agricultural Technology Argentine
Speaker: John Lewis - Entos Pharmaceuticals
Speaker: Megan Stanifer - University of Florida
Speaker: Jonathan Mandolo - Malawi Liverpool Wellcome Trust
Speaker: Ming Tan - Cincinnati Children's Hospital Medical Center
Speaker: Jacqueline Tate - Centers for Disease Control
Speaker: John Lewis - Entos Pharmaceuticals
Speaker: Megan Stanifer - University of Florida
Speaker: Jonathan Mandolo - Malawi Liverpool Wellcome Trust
Speaker: Ming Tan - Cincinnati Children's Hospital Medical Center
Speaker: Jacqueline Tate - Centers for Disease Control
Description
|
10:45 - 10:50 am |
Name: | Viviana Parreno |
| Topic: | Introduction | |
|
10:50 - 11:15 am |
Name: | John Lewis |
| Topic: | Development of a COVID-19 DNA Vaccine Formulated with the Fusion-Associated Small Transmembrane Protein Proteolipid Vehicle Delivery System | |
|
11:15 - 11:30 am |
Name: | Megan Stanifer |
| Topic: | Type-III and Not Type-I Interferons Efficiently Prevent the Spread of Rotavirus in Human Intestinal Epithelial Cells | |
|
11:30 - 11:45 am |
Name: | Jonathan Mandolo |
| Topic: | Maternal Breast Milk Microbiota Negatively Correlates with the Immunogenicity of Rotavirus Vaccine in Malawi: a prospective cohort study | |
|
11:45 am - 12:00 pm |
Name: | Ming Tan |
| Topic: | An Pseudovirus Nanoparticle-Based Trivalent Rotavirus Vaccine Candidate Elicits High and Broad Immune Responses Towards the Predominant Rotavirus P Types |
Session Type
Workshop
Building
Kinnear Centre
Room
Husky Great Hall 103/105